Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 373

Results For "NAL"

6627 News Found

Vaniam appoints Paula Franson to lead Clinical Strategy & Solutions
People | April 18, 2023

Vaniam appoints Paula Franson to lead Clinical Strategy & Solutions

Franson will help biopharma clients design a phased approach to inform and execute clinical development plans


Ascentage presents results of studies underscoring exploratory efforts in potential
Clinical Trials | April 18, 2023

Ascentage presents results of studies underscoring exploratory efforts in potential

The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications


DualityBio collaborates with BioNTech to accelerate development of differentiated antibody-drug conjugate therapeutics
Biotech | April 18, 2023

DualityBio collaborates with BioNTech to accelerate development of differentiated antibody-drug conjugate therapeutics

WuXi Bio provided technical services, based on the companies' versatile integrated service platforms, to support various manufacturing and process development activities of these ADC product candidates.


Agilent showcases cancer portfolio Solutions at AACR 2023
Digitisation | April 18, 2023

Agilent showcases cancer portfolio Solutions at AACR 2023

From cancer research to diagnostic solutions


CII co-organizes Digital Health Summit 2023 with Health Ministry
Digitisation | April 17, 2023

CII co-organizes Digital Health Summit 2023 with Health Ministry

The Theme of the event was 'Building One Health Together – Improving Health Equity'


Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline
News | April 17, 2023

Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline

Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology


NS Pharma announces FDA clearance to initiate phase II study for an Exon 44 skipping candidate
Drug Approval | April 15, 2023

NS Pharma announces FDA clearance to initiate phase II study for an Exon 44 skipping candidate

Study efficacy measures will include the expression of dystrophin protein and motor function.


Alpenglow Biosciences and Mayo Clinic collaborate to advance pathology and drug development through 3D spatial biology
Clinical Trials | April 15, 2023

Alpenglow Biosciences and Mayo Clinic collaborate to advance pathology and drug development through 3D spatial biology

Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging


Taros Chemicals and Welab Barcelona partner for drug Discovery and development services
News | April 15, 2023

Taros Chemicals and Welab Barcelona partner for drug Discovery and development services

The combination will support clients in getting their end-to-end discovery and development programs delivered.


Chiesi Farmaceutici completes acquisition of Amryt Pharma
News | April 15, 2023

Chiesi Farmaceutici completes acquisition of Amryt Pharma

Acquisition positions Chiesi to expand patient access to approved treatments and advance efforts to develop new treatments for people living with rare diseases.